NCT06097806

Brief Summary

Low flow anesthesia; It is an anesthesia practice in which, after absorbing at least 50% of the exhaled air and carbon dioxide (CO2) using a semi-closed rebreathing system, the unused anesthetic gases are mixed with a certain amount of fresh gas and then completely or partially returned to the patient in the next inspiration. Theoretically, when low flow anesthesia is compared to high or normal flow anesthesia; it is known to have advantages such as using less inhalation agent, preserving mucociliary activity, preventing microatelectasis, preserving the amount of moisture, and reducing temperature loss. In studies conducted in different fresh gas flows, it has been observed that CO, which is thought to accumulate in the body by rebreathing in a closed circuit, increases as a result of the chemical interaction and dry CO2 absorbent. However, there is no evidence in these studies that low-flow anesthesia increases CO accumulation and alters hemodynamics. In our clinic, low-flow and high-flow anesthesia technics are both being used. In this study, we aimed to evaluate the effects of high- and low-flow sevoflurane anesthesia applied with a closed system on perioperative carboxyhemoglobin (COHb) levels and hemodynamic system in pediatric cardiovascular surgery cases.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 24, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

October 6, 2023

Last Update Submit

May 18, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • COHb levels

    COHb values will be measured in arterial blood gas samples at different fresh gas flow levels.

    at the 30th minute of the surgery, at the beginning of cardiopulmonary bypass, at the time of chest closure, at the time of intensive care unit admission

Secondary Outcomes (4)

  • extubation time

    at the time that patient is extubated up to 24 hours

  • body temperature

    at the 30th minute of the surgery, at the beginning of cardiopulmonary bypass, at the time of chest closure, at the time of intensive care unit admission

  • bleeding

    24 hours

  • vasoactive inotrope score (VIS)

    postoperative first hour

Study Arms (2)

Low-flow anesthesia group

In this group, ventilation parameters is adjusted to have fresh gas flow/minute ventilation ratio below 0.5

Other: low and high flow

High-flow anesthesia group

In this group, ventilation parameters is adjusted to have fresh gas flow/minute ventilation ratio above 1.0

Other: low and high flow

Interventions

low and high flow anesthesia are both being used. The effects of different gas flows will be evaluated.

High-flow anesthesia groupLow-flow anesthesia group

Eligibility Criteria

Age2 Months - 7 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients will be selected among the patients who will undergo cardiac surgery at Basaksehir Cam and Sakura City Hospital Pediatric Cardiovascular Surgery Clinic.

You may qualify if:

  • Patients between the ages of 2 months and 7 years undergoing elective cardiac surgery
  • American Society of Anesthesiology (ASA) score II ve III patients

You may not qualify if:

  • Patients undergoing emergency surgery
  • Patients who need mechanical ventilation or any respiratory support before the operation
  • Patients with left to right shunt
  • cyanotic patients
  • Patients younger than 2 months and older than 7 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Basaksehir Cam and Sakura City Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist

Study Record Dates

First Submitted

October 6, 2023

First Posted

October 24, 2023

Study Start

June 1, 2024

Primary Completion

November 1, 2024

Study Completion

November 1, 2025

Last Updated

May 21, 2024

Record last verified: 2024-05

Locations